SignatureFD’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-59
| Closed | -$402 | – | 3251 |
|
|
2024
Q2 | $402 | Hold |
59
| – | – | ﹤0.01% | 2996 |
|
|
2024
Q1 | $149 | Hold |
59
| – | – | ﹤0.01% | 3109 |
|
|
2023
Q4 | $142 | Hold |
59
| – | – | ﹤0.01% | 3068 |
|
|
2023
Q3 | $201 | Hold |
59
| – | – | ﹤0.01% | 3085 |
|
|
2023
Q2 | $434 | Sell |
59
-1,423
| -96% | -$10.5K | ﹤0.01% | 3073 |
|
|
2023
Q1 | $15.4K | Sell |
1,482
-489
| -25% | -$5.07K | ﹤0.01% | 2014 |
|
|
2022
Q4 | $23.3K | Buy |
1,971
+1,879
| +2,042% | +$22.2K | ﹤0.01% | 1726 |
|
|
2022
Q3 | $2K | Sell |
92
-115
| -56% | -$2.5K | ﹤0.01% | 2754 |
|
|
2022
Q2 | $6K | Buy |
207
+7
| +4% | +$203 | ﹤0.01% | 2357 |
|
|
2022
Q1 | $8K | Sell |
200
-89
| -31% | -$3.56K | ﹤0.01% | 2245 |
|
|
2021
Q4 | $13K | Buy |
289
+124
| +75% | +$5.58K | ﹤0.01% | 1976 |
|
|
2021
Q3 | $8K | Buy |
165
+110
| +200% | +$5.33K | ﹤0.01% | 2165 |
|
|
2021
Q2 | $3K | Sell |
55
-11
| -17% | -$600 | ﹤0.01% | 2431 |
|
|
2021
Q1 | $6K | Sell |
66
-25
| -27% | -$2.27K | ﹤0.01% | 2052 |
|
|
2020
Q4 | $8K | Sell |
91
-121
| -57% | -$10.6K | ﹤0.01% | 1776 |
|
|
2020
Q3 | $22K | Buy |
212
+157
| +285% | +$16.3K | ﹤0.01% | 1321 |
|
|
2020
Q2 | $4K | Buy |
55
+12
| +28% | +$873 | ﹤0.01% | 1869 |
|
|
2020
Q1 | $2K | Buy |
43
+8
| +23% | +$372 | ﹤0.01% | 1917 |
|
|
2019
Q4 | $2K | Hold |
35
| – | – | ﹤0.01% | 1862 |
|
|
2019
Q3 | $2K | Hold |
35
| – | – | ﹤0.01% | 1795 |
|
|
2019
Q2 | $2K | Hold |
35
| – | – | ﹤0.01% | 1746 |
|
|
2019
Q1 | $2K | Hold |
35
| – | – | ﹤0.01% | 1762 |
|
|
2018
Q4 | $2K | Hold |
35
| – | – | ﹤0.01% | 1710 |
|
|
2018
Q3 | $2K | Hold |
35
| – | – | ﹤0.01% | 1679 |
|
|
2018
Q2 | $2K | Hold |
35
| – | – | ﹤0.01% | 1707 |
|
|
2018
Q1 | $2K | Buy |
+35
| New | +$2K | ﹤0.01% | 1541 |
|